News Polsky Center and Chicago Booth Private Equity Group Host 25th Annual PE Conference Investors, students, and industry leaders gathered last week for the 25th Annual Chicago Booth Private Equity Conference, a day-long event exploring the evolving dynamics of private equity investing and value...
News The Coasts Don’t Own Innovation. They Just Own the Capital. Innovation is no longer confined to a few coastal cities. We know that well in the Midwest. Across the region, our universities, research labs, and entrepreneurs are launching companies in...
Technology A Potent Glioma Targeting CAR T-Cell With Minimal Off-Target Toxicity IL13Ra2 is a cancer testis antigen that is expressed in 50-80% of glioblastoma cells, has no basal expression in the healthy tissue, and is correlated with poor patient prognosis. Problematically,…
Technology Immune Modulatory Small Molecules for the Treatment of Sepsis and Autoimmune Diseases Tumor necrosis factor alpha (TNFα) is an important cytokine that activates cell death programs in response to acute inflammation. TNFα inhibitors are currently used to treat a multitude of autoimmune…
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
Program Our Process and Advisory Committee Our Process The George Shultz Innovation Fund invests in promising startups from an ecosystem that includes the University of Chicago, Argonne National Laboratory, Fermilab, and the Marine Biological Laboratory. The...
Program ETA Advisory Committee Comprised of leading operators, investors, and academics in the ETA space, the Polsky Center ETA Advisory Committee is instrumental in providing guidance to the growth and impact of our ETA...
